StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Treasury Share Repurchases Cash Outflow by Quarter

Treasury Share Repurchases Cash Outflow ($M)

QuarterlyAnnual

Novartis Treasury Share Repurchases Cash Outflow: $1,698M in Q3 2026, down 26.2% from a year earlier.

Latest, Q3 2026
1,698
Period ended Sep 30, 2026
Change on a year earlier
-26.2%
2,302 in Q3 2025
History
18 quarters
Since Q2 2022
Sources
14
Documents cited below

Where the Q3 2026 figure comes from

“|| Purchases of treasury shares | – 1 698 | – 2 302”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K Cash Flow & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTreasury Share Repurchases Cash Outflow ($M)Year on yearSource
Q3 2026Sep 30, 20261,698-26.2%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20261,199-55.8%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20261,875-31.0%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20251,480-46.4%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20252,302-19.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20252,714+67.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20252,716+147.1%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20242,762+120.8%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20242,854+75.6%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20241,616-45.4%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20241,099-61.9%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20231,251-53.3%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20231,625-40.2%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,957+9.0%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20232,886–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20222,678–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Treasury Share Repurchases Cash Outflow ($M), quarterly Q2 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/cf-buyback-quarterly-usd

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.